Literature DB >> 3919855

Prolactinomas.

R Hall, S H Richards, M F Scanlon, J P Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3919855      PMCID： PMC1418300          DOI： 10.1136/bmj.290.6473.1002-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Treatment of prolactinomas with megavoltage radiotherapy.

Authors:  G Teasdale; J A Thomson; P Macpherson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

2.  Treatment of prolactinomas with megavoltage radiotherapy.

Authors:  A Grossman; B L Cohen; M Charlesworth; P N Plowman; L H Rees; J A Wass; A E Jones; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

3.  Surveillance of bromocriptine in pregnancy.

Authors:  I Turkalj; P Braun; P Krupp
Journal:  JAMA       Date:  1982-03-19       Impact factor: 56.272

4.  Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma.

Authors:  O Serri; E Rasio; H Beauregard; J Hardy; M Somma
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

5.  Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumors.

Authors:  T Bergh; S J Nillius; L Wide
Journal:  Br Med J       Date:  1978-04-08
  5 in total
  2 in total

1.  Transparency of Outcome Reporting and Trial Registration of Randomized Controlled Trials Published in the Journal of Consulting and Clinical Psychology.

Authors:  Marleine Azar; Kira E Riehm; Dean McKay; Brett D Thombs
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

2.  Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events.

Authors:  Evan Mayo-Wilson; Nicole Fusco; Hwanhee Hong; Tianjing Li; Joseph K Canner; Kay Dickersin
Journal:  Trials       Date:  2019-09-05       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.